Create stable, long-term investment portfolio with strong, consistent stocks.
Start Research-backed Investing ...Now.
Advanced Enzyme Technologies is currently trading at Rs. 332.90, up by 7.80 points or 2.40% from its previous closing of Rs. 325.10 on the BSE.
The scrip opened at Rs. 336.90 and has touched a high and low of Rs. 339.10 and Rs. 330.55 respectively. So far 2732 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 384.75 on 08-Oct-2020 and a 52 week low of Rs. 91.05 on 23-Mar-2020.
Last one week high and low of the scrip stood at Rs. 343.00 and Rs. 299.15 respectively. The current market cap of the company is Rs. 3632.14 crore.
The promoters holding in the company stood at 55.45%, while Institutions and Non-Institutions held 22.33% and 22.23% respectively.
Advanced Enzymes Technologies’ board has approved the investment of an amount not exceeding Rs 316.26 million by way of subscription to the issue of 492,630 equity shares of SciTech Specialties (SSPL), as may be offered on preferential issue / private placement basis by SSPL and purchase of 27,778 from selling shareholders of SSPL, aggregating to 520,408 equity shares i.e. 51% of equity share capital of SSPL and authorization for signing of Share Subscription and Shareholders' Agreement in this regard. On completion of the aforesaid investment, SSPL will become subsidiary of the company. The Board of Directors of the company in its meeting held on December 26, 2020 has approved the same.
Advanced Enzymes Technologies is a research driven company with global leadership in manufacturing of enzymes and probiotics. It is the largest Indian enzyme company engaged in the research and development, manufacturing and marketing of vast proprietary products developed from many indigenous enzymes & probiotics.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1530.00 |
| Dr. Reddys Lab | 5802.00 |
| Cipla | 1399.35 |
| Zydus Lifesciences | 1051.90 |
| Lupin | 1653.75 |
| View more.. | |
MoneyWorks4Me rating and ranking of funds for SIP is available to subscribers only. Moneyworks4Me is not a rating and ranking agency, however it is required that users have a way of selecting funds and building a Portfolio. The method used by it are described below to enable users to understand the logic behind the rating and ranking Subscriber will find more details on this in the various content made available from time to time. In case you need more please write to besafe@moneyworks4Me.com
MoneyWorks4Me rates and ranks mutual funds based on the following data-driven system:
Funds ranking in screeners: Performance Consistency and Quality are two parameters used for ranking funds for SIP. The ranking as follows GG, GO, GR, OG, OO, OR, RG, RO and RR.
With the same color-coded funds, the one with the higher Average 3-year rolling returns (over 5 to 10 years), the number that appears in the Performance tag, ranks higher.
Here is the summary:
The third tag Upside Potential is not relevant for SIP. It is relevant for lumpsum investments in Mutual Funds.
Buy quality Stocks when they are available at reasonable prices and supported by an upward price trend and Sell when they are Overvalued using the Decizen Rating System. Covers 3500+ stocks
Download APP
